Mary Ellen Frustaci

740 citations
17 papers · 509 indexed · 1 hit paper · h-index 10
Topics
Inflammatory Bowel Disease (5 papers)Chronic Lymphocytic Leukemia Research (4 papers)Pain Mechanisms and Treatments (4 papers)

In The Last Decade

Mary Ellen Frustaci

17 papers receiving 497 citations

Hit Papers

Guselkumab for the Treatment of Crohn’s Disease: Inductio...202220262023202420224080120

Peers

Mary Ellen Frustaci
Comparison fields: 5 of 58
  • Endocrinology, Diabetes and Metabolism 178
  • Genetics 165
  • Pharmacology 160
  • Physiology 134
  • Epidemiology 123
Replace Jonathan M. Williams with:
Jonathan M. Williams United States
Dong-Mee Lim South Korea
Stefanie Y. Tan United States
Bartłomiej Kisiel Poland
Huaqing Zheng China
Ann Dunne Netherlands
Oak‐Kee Hong South Korea
Toshiharu Onodera Japan
Elizabeth A. Rick United States
Osvaldo Tiscornia Argentina
Mary Ellen Frustaci relative to Jonathan M. Williams United States Jonathan M. Williams's profile →
Citations per field
00.5×5.5×
Jonathan M. Williams · 1×
Citations per year

Countries citing papers authored by Mary Ellen Frustaci

Since Specialization
Citations

This map shows the geographic impact of Mary Ellen Frustaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ellen Frustaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ellen Frustaci more than expected).

Fields of papers citing papers by Mary Ellen Frustaci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ellen Frustaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ellen Frustaci. The network helps show where Mary Ellen Frustaci may publish in the future.

Co-authorship network of co-authors of Mary Ellen Frustaci

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ellen Frustaci. A scholar is included among the top collaborators of Mary Ellen Frustaci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ellen Frustaci. Mary Ellen Frustaci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 22
2 18
3
Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Studybreakdown →
132
4 44
5 68
6 1
7 1
8 2
9 8
10 4
11 34
12 90
13 17
14 25
15 38
16 1
17 4

About Mary Ellen Frustaci

Mary Ellen Frustaci is a scholar working on Genetics, Neurology and Pharmacology, having authored 17 papers that have together received 509 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Pain Mechanisms and Treatments (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (178 citations), Pharmacology (160 citations) and Genetics (165 citations). Mary Ellen Frustaci has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Mahesh N. Samtani, Maria Alba, P. Fleck, Harold Bays, Ngozi Erondu, Albert Fung, Frank Vercruysse, Julio Rosenstock, Priscilla Hollander and David T. Rubin. Their work appears in journals such as Gastroenterology, Neurology and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026